| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2006) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | S01LA04 |
| UNII: | ZL1R02VT79 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Vascular endothelial growth factor A inhibitor | DailyMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Macular Edema | 4 | D008269 | ClinicalTrials |
| Diabetic Retinopathy | 4 | D003930 | ClinicalTrials |
| Macular Degeneration | 3 | D008268 | ClinicalTrials |
| Glaucoma | 3 | D005901 | ClinicalTrials |
| Retinal Vein Occlusion | 3 | D012170 | ClinicalTrials |
| Macular Degeneration | 3 | D008268 | ClinicalTrials |
| Retinopathy of Prematurity | 3 | D012178 | ClinicalTrials |
| Myopia, Degenerative | 3 | D047728 | ClinicalTrials |
| Blindness | 3 | D001766 | ClinicalTrials |
| Glaucoma, Neovascular | 3 | D015355 | ClinicalTrials |
| Histoplasmosis | 2 | D006660 | ClinicalTrials |
| Pterygium | 2 | D011625 | ClinicalTrials |
| Telangiectasis | 2 | D013684 | ClinicalTrials |
| Retinoblastoma | 2 | D012175 | ClinicalTrials |
| Retinal Diseases | 2 | D012164 | ClinicalTrials |
| Retinal Detachment | 2 | D012163 | ClinicalTrials |
| Diabetes Mellitus | 2 | D003920 | ClinicalTrials |
| Port-Wine Stain | 1 | D019339 | ClinicalTrials |
| Myopia | 1 | D009216 | ClinicalTrials |
| Corneal Neovascularization | 1 | D016510 | ClinicalTrials |
| Optic Neuropathy, Ischemic | 1 | D018917 | ClinicalTrials |
| Glaucoma, Open-Angle | 1 | D005902 | ClinicalTrials |
| Angioid Streaks | 1 | D000793 | ClinicalTrials |
| von Hippel-Lindau Disease | 1 | D006623 | ClinicalTrials |
| Central Serous Chorioretinopathy | 1 | D056833 | ClinicalTrials |
| Conjunctival Neoplasms | 1 | D003230 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 347396-82-1 |
| ChEMBL | CHEMBL1201825 |
| FDA SRS | ZL1R02VT79 |
| Guide to Pharmacology | 6779 |
CONTENTS